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Supplementary Tables 1 
Cell 
Line 
Patient 
ID Sex Disease-related Genotype Clinical Phenotype Notes Reference 
SIR1 P894 M 
PPARG p.Leu441Leu_fs*9 
heterozygote 
Familial partial 
lipodystrophy type 3  Unpublished 
SIR2 P672 F 
INSR 
p.Val93Ala/ 
del exon 18 
Rabson Mendenhall 
syndrome  
P16 in Simpkin et al 
(Simpkin, Cochran et al. 
2014) 
SIR3 P0014 F 
LMNA 
p.Arg482Trp heterozygote 
Familial partial 
lipodystrophy type 2 
Common 
FPLD2 
mutation 
Kumar et al (Kumar, 
Durrington et al. 1996) 
SIR4 P340 M 
BSCL2 
c.1324delC/ p.Ala276fs*20 
Congenital generalised 
lipodystrophy 
Most severe 
form of 
generalised 
lipodystrophy 
unpublished 
SIR5 P13 M 
ALMS1 
p.Thr3591Ilefs*5/p.Thr3591ilefs*5 
Alström syndrome Subject P13 in (Chen, Geberhiwot et al. 2017)  
SIR6 P621 F 
PIK3R1 
p.Tyr657* heterozygote 
SHORT syndrome  
Huang-Doran et al 
(Huang-Doran, Tomlinson 
et al. 2016) 
SIR7  M WRN* Werner syndrome  AG12795 (Coriell Institute) 
SIR8  M 
BLM* 
Homozygous for a 6 p deletion/ 7bp 
insertion at nucleotide 2,281of the open 
reading frame of the RECQL3 gene 
Bloom syndrome  GM02932 (Coriell Institute) 
SIR9 P384 F 
NSMCE2 
p.Ser116Leufs*18/ p.Ala234Glufs*4 
Primordial dwarfism with 
extreme IR  
Patient 1 in Payne et al 
(Payne, Colnaghi et al. 
2014) 
SIR10 P689 F 
PCYT1A 
p.Glu280del 
p.Ser333Leufs*164 
Generalised 
lipodystrophy  
Proband 2 in Payne et al 
(Payne, Lim et al. 2014) 
SIR11 P616 F 
PCYT1A 
p.Glu280del/  
p.Val142Met 
Generalised 
lipodystrophy  
Proband 1 in Payne et al 
(Payne, Lim et al. 2014) 
Supplementary Table S1. Clinical and Genetic Diagnoses of Volunteers Contributing Dermal 2 
Fibroblasts for Study. *WRN and BLM deficient cells were purchased from Coriell Institute, catalogue 3 
numbers AG12795 and GM02932 respectively. Precise mutations were not available. 4 
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Gene Forward primer (5′ to 3′) Reverse primer (5′ to 3′) Amplicon 
size (bp) 
ADIPOQ GGGTGGGCTCCTTACAGAAC CTCTCTGTGCCTCTGGTTCC 89 
FABP4 TACTGGGCCAGGAATTTGAC TGCACATGTACCAGGACACC 91 
CEBPA GAGGAGGGGAGAATTCTTGG GAGCGGTGAGTTTGCATTTC 92 
GLUT4 AGTTCCAGCCATGAGCTACG CCACGATGAACCAAGGAATG 95 
LEP CCAGGTAATGAGGGACTGGA CATCCCTCACCTCCTTCAAA 88 
UCP1 AGTGTGCCCAACTGTGCAAT AATGACGTTCCAGGATCCAA 105 
CYC1 AGAGCACGACCATCGAAAAC TCAGGACTGACCACTTGTGC 104 
ELOVL3 CCTGGGTCTTTCTTCTCAGC GTGCTGTGGTGGTACCAGTG 103 
DIO2 AGACCCAGCTCTGTTCCAAG TCTGCTGTTGCTGCCTAAGA 119 
HPRT1 AGTTCTGTGGCCATCTGCTT TAGGAATGCAGCAACTGACA 96 
BSCL2 ACGTGATCGGGTGCTGATGT GGATGTTAACCTGCAAAGAG 538 
PPARG TCTCAGTGGAGACCGCCCAGGTT GCAGTGGCTCAGGACTCTCT 280 
Supplementary Table S2. Primers used for quantitative RT-PCR and mutation 1 
confirmation 2 
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Supplementary Figures 1 
 2 
Supplementary Figure S1. Direct reprogrammed adipocyte-like cells can be 3 
maintained in culture for a long time in the continuous presence of doxycycline. 4 
Shown are two images at different magnifications for reprogrammed cells maintained in 5 
culture for 70 days. (scale bar: top, 200µm, bottom, 40µm). 6 
 7 
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Supplementary Figure S2. Leptin gene expression of secretion of reprogrammed 2 
adipocyte-like cells. (A) Quantitative RT-PCR analysis of leptin gene expression. (B) Leptin 3 
secretion in 48 hour culture was determined with DELFIA. Data from three independent 4 
experiments are represented as mean ± SEM (*P<0.05, ***P<0.001, t-Test). 5 
 6 
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Supplementary Figure S3. Expression of brown adipocyte-specific genes (A) and 2 
UCP1 protein (B) in reprogrammed adipocyte-like cells. Expression was determined by 3 
quantitative RT-PCR and Western blotting respectively. A rat brown adipose sample was 4 
used as a positive control (“+ve”) in the Western blotting. Data from three independent 5 
experiments are represented as mean ± SEM (**P<0.01, ***P<0.001, t-Test). 6 
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Supplementary Figure S4. Overexpression of C/EBPα and adipogenic differentiation 2 
of dermal fibroblasts infected with C/EBPα lentivirus alone or together with PPARγ2 3 
lentivirus. (A) Western blot analysis of kinetics of PPARγ2 overexpression in human dermal 4 
fibroblasts transduced with pSLIK-C/EBPα recombinant lentivirus, which were cultured in the 5 
presence of DOX (1 µg/ml) followed by DOX withdrawal for the indicated length of time. 6 
Equal loading was revealed by calnexin antibody. (B) Representative images of adipocyte-7 
like cells that accumulated lipid droplets upon DOX induction of C/EBPα overexpression (α) 8 
or co-overexpression of C/EBPα and PPARγ2 (α/γ) at adipogenic differentiation day 9. (scale 9 
bar: 10µm). (C) Western blot analysis of C/EBPα,  PPARγ2, and adiponectin in cells that had 10 
been subjected for adipogenic differentiation in the presence or absence of DOX for 9 days. 11 
Loading was revealed by calnexin antibody as well as Coomassie staining. (D) Western blot 12 
analysis of Glut4 expression in cells as in (C) above using unboiled samples. Equal loading 13 
was revealed by Coomassie staining. Note the uneven exposure of the blot that resulted in 14 
lighter bands coinciding with the first lane on the left hand side. 15 
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Supplementary Figure S5. Protocol of adipogenic differentiation via pluripotent stem 2 
cell stage. Overview of the protocol for deriving adipocytes from pluripotent stem cells. (A) 3 
Pluripotent stem cells were first differentiated into embryoid bodies (EBs) from which 4 
adipocyte precursor (AP) cells were derived. (B) Schematic showing adipogenic 5 
differentiation protocol which consists of DOX induction in the presence of adipogenic 6 
cocktail for the indicated time. DOX was included in the medium until day 16 or day 21 and 7 
cells were used for analysis either on the same day when DOX was withdrawn or 7 days 8 
after DOX withdrawal. Oil Red O staining showing a successful conversion of adipocyte 9 
precursors (Day 0) into triglyceride-laden adipocyte-like cells (Day 28). 10 
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Supplementary Figure S6. Characterisation of adipocyte-like cells obtained using a 2 
protocol described in Supplementary figure 6. For details of quantitative RT-PCR (A), 3 
ELISA, lipolysis assay and glucose uptake assay (B), see above respective figure legends. 4 
Data from three independent experiments are represented as mean ± SEM (*P<0.05, 5 
***P<0.001, t-Test). 6 
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Supplementary Figure S7. Marked decrease in expression of adipocyte specific genes 2 
in mature differentiated adipocyte-like cells 7 days after withdraw of PPARγ2 3 
overexpression inducing reagent DOX. Endogenous PPARγ (ePPARG) expression was 4 
determined by RT-PCR using a pair of primers specific to a 3’-UTR region immediately after 5 
PPARg stop codon while pSLIK-PPARγ2 expression was determined by RT-PCR using a 6 
forward primer that is specific to a vector sequence immediately before the PPARγ2 open 7 
reading frame and a reverse primer that is specific to a PPARγ2 open reading frame 8 
sequence at the 5’ end. Data from three independent experiments are represented as mean 9 
± SEM (***P<0.001, t-Test). 10 
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Supplementary Figure S8. Delipidation of mature differentiated adipocyte-like cells via 2 
pluripotent stem cell stage using protocol described in supplementary Figure S6 did 3 
not occur 7 days after withdraw of PPARγ2 overexpression inducing reagent DOX. 4 
(scale bar: 200 µm) 5 
  6 
Evaluation of human dermal fibroblasts directly reprogrammed to adipocyte-like cells 
as a metabolic disease model  
Chen et al 
 
11 
 
 1 
Evaluation of human dermal fibroblasts directly reprogrammed to adipocyte-like cells 
as a metabolic disease model  
Chen et al 
 
12 
 
Supplementary Figure S9. Direct reprogramming of dermal fibroblasts derived from 1 
an Alström Syndrome patient. (A) Confocal immunofluorescence analysis revealed 2 
absence of ALMS1 at centrosome and the basal body of primary cilium in the patient cells 3 
due to the disease causing mutations on the ALMS1 gene. (scale bar: 5 µm) (B) Oil Red O 4 
staining showing a successful conversion of ALMS1 dermal fibroblasts into adipocyte-like 5 
cells. (scale bar: 200 µm) (C) Quantitative RT-PCR analysis of expression of marker genes 6 
of white adipocytes at four different differentiation time points. (D) Western blot analysis of 7 
key proteins in adipocyte-like cells during direct reprogramming up to day 18, using 8 
antibodies as indicated. (E) Adiponectin secretion from direct reprogrammed adipocyte-likes 9 
cells. 48 hour culture media were determined with DELFIA. (F) Glucose uptake assay. (G) 10 
Lipolysis assay of direct reprogrammed adipocyte-like cells treated with isoprotenerol and/or 11 
IBMX. Data from three independent experiments are represented as mean ± SEM 12 
(**P<0.01, ***P<0.001, t-Test). 13 
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Supplementary Figure S10. Direct reprogramming of dermal fibroblasts derived from 2 
lipodystrophy patients harbouring mutations on WRN, BLM, NSMCE2, PIK3R1 and 3 
PCYT1A genes. (scale bar: 200 µm) 4 
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